first generation glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Orforglipron FDA Approval: Why the

Here is where the public conversation goes off the rails: weight regain after stopping treatment is being framed as evidence that treatment is not worth it, or that patients are stuck on it for life, as if that is a moral failing or some unique downside in obesity care

Modifications: Dulaglutide consists of 2 disulfide-linked chains, and each is about 90% homologous to GLP-1

The clinical translation of these trial results, which will be important for the comparison of GLP-1RAs with SGLT2 inhibitors in the treatment of patients with heart failure and a preserved ejection fraction, remains to be determined

One thing youve probably noticed